News Column

REVA MEDICAL, INC. FILES (8-K) Disclosing Regulation FD Disclosure, Financial Statements and Exhibits

May 13, 2014

Item 7.01 Regulation FD Disclosure.

Robert B. Stockman, the Chairman of the Board and Chief Executive Officer of REVA Medical, Inc. ("REVA"), made a presentation at the Annual Meeting of Stockholders of REVA, held on 13 May 2014, at 10:30 a.m., Australian Eastern Standard Time (which was 5:30 p.m. on May 12, 2014 U.S. Pacific Daylight Time) in Sydney, Australia. The presentation materials delivered at the Annual Meeting of Stockholders are attached hereto as Exhibit 99.1. A copy of the materials has also been posted under the Investor Relations section of REVA's website at

Limitation of Incorporation by Reference

In accordance with General Instruction B.2. of Form 8-K, this information including Exhibit 99.1, is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Item 7.01 of this Current Report on Form 8-K will not be deemed an admission as to the materiality of any information that is required to be disclosed solely by Regulation FD.

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Annual Meeting of Stockholders Presentation 2


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters